My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2011
Global ID
Armed with Research on Early HIV Treatment, HIVMA and Global Center Make Case for More Funding

The Center for Global Health Policy and HIVMA released a policy statement (PDF) this month, calling for greater investment domestically and globally in HIV treatment in light of the results of the HIV Prevention Trial Networks (HPTN) 052 study. The study found that early initiation of antiretroviral therapy (ART) for HIV-infected patients reduced their chances of sexually transmitting HIV to their uninfected partners by more than 96 percent.  

The Center and HIVMA recommend that a larger share of the President's Emergency Plan for AIDS Relief (PEPFAR) budget be devoted to treatment; that ART be included in studies of combination prevention strategies, and that HIV counseling and testing, including couples counseling, be expanded in all venues. The policy statement also calls for an evaluation of PEPFAR prevention expenditures based on evidence of efficacy and a redeployment of resources from less efficacious interventions to those known to be effective, including ART.

In addition, the groups call for prioritizing domestic HIV funding for early HIV diagnosis with reliable and ongoing linkage and access to HIV care and treatment; and for fully funding the Ryan White program and addressing state waiting lists for ART medication.

Check out the Science Speaks blog for more information.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
CDC Makes New Recommendations for Influenza Immunization
EIN Update: CBC Monitoring for ID-Related Diseases
Drug Approvals, Recalls, Adverse Events Update
Global ID
Armed with Research on Early HIV Treatment, HIVMA and Global Center Make Case for More Funding
Congressional Staff Tours U.S.-funded HIV and TB programs in Kenya with Global Center
Science Speaks Interviews Key PEPFAR Staff
Policy and Advocacy
Policy Conference Addresses Lack of New Antibiotics
FDA Rolls Out New Foodborne Illness Response Network
Input Due Oct. 26 on Changes to Rules Protecting Human Research Subjects
IDSA Urges Fix to Flawed Medicare Physician Payment Formula
Your Colleagues
IDSA Congratulates the 2011 Joint Research Award Winners
Congratulations to the 2011 Medical Scholars Program Recipients
In Memoriam: Richard B. Hornick, MD, FIDSA (1929-2011)
Members on the Move
Welcome, New Members!
Education & Resources
New Toolkit Aims to Increase Pneumococcal Immunization in Adults
HIVMA Minority Clinical Fellowship Program: December 9 Application Deadline
Top Stories
From the President: A Year in Review
IDSA, PIDS Release Guidelines for Treating CAP in Children
Quick Guide to the New IDSA Website
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.